Cargando…
Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up
BACKGROUND: Due to the outbreak and rapid spread of coronavirus disease 2019 (COVID-19), more than 160 million patients have become convalescents worldwide to date. Significant alterations have occurred in the gut and oral microbiome and metabonomics of patients with COVID-19. However, it is unknown...
Autores principales: | Cui, Guang-Ying, Rao, Ben-Chen, Zeng, Zhao-Hai, Wang, Xue-Mei, Ren, Tong, Wang, Hai-Yu, Luo, Hong, Ren, Hong-Yan, Liu, Chao, Ding, Su-Ying, Tan, Jun-Jie, Liu, Zhen-Guo, Zou, Ya-Wen, Ren, Zhi-Gang, Yu, Zu-Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204369/ https://www.ncbi.nlm.nih.gov/pubmed/35715833 http://dx.doi.org/10.1186/s40779-022-00387-y |
Ejemplares similares
-
Alterations in the human oral microbiome in cholangiocarcinoma
por: Rao, Ben-Chen, et al.
Publicado: (2022) -
Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
por: Zou, Yawen, et al.
Publicado: (2023) -
Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Rao, Benchen, et al.
Publicado: (2021) -
Gut Microbiome and Plasma Metabolomic Analysis in Patients with Myelodysplastic Syndrome
por: Jiang, Huijuan, et al.
Publicado: (2022) -
Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals
por: Cui, Guangying, et al.
Publicado: (2022)